National Health Investors stock hits new 52-week low as FY 2026 guidance and dividend support valuation

National Health Investors, Inc. stock (ISIN US6374321057) traded down to a new 52-week low of USD 67.56 on the New York Stock Exchange on September 18, 2026, compared with a prior close of USD 69.23, corresponding to a single-session decline of about 2.4 percent based on data cited by MarketBeat.

Stock under pressure at bottom of 52-week range

As reported by Ad-hoc-news on September 19, 2026, National Health Investors stock traded in an intraday range that saw a low of USD 67.56 and a last trade reported around USD 67.79 on September 18, 2026, with turnover of 92,454 shares on the New York Stock Exchange.

According to the same price snapshot from Ad-hoc-news, the new low of USD 67.56 marked the bottom of the REIT’s 52-week trading band as of September 18, 2026, with the shares now clearly below their 50-day and 200-day moving averages.

FY 2026 guidance and valuation context

Per coverage of the company’s outlook by Ad-hoc-news referencing MarketBeat data, National Health Investors has confirmed FY 2026 guidance with a projected earnings per share range of USD 4.74 to USD 4.79.

At a share price around USD 67.79 as of September 18, 2026, the midpoint of that FY 2026 EPS guidance implies a price-to-earnings multiple slightly above 14 times expected earnings, placing the REIT in a moderate valuation range relative to peers in the healthcare property segment according to the analysis cited by Ad-hoc-news.

The quantified comparison between the new 52-week low of USD 67.56 and the prior close of USD 69.23 on September 18, 2026, underscores how quickly sentiment shifted, with the roughly 2.4 percent drop pushing the shares to the very bottom of their yearly trading band as highlighted by Ad-hoc-news.

Dividend remains a key attraction for income-focused investors

Income continues to be a central part of the investment case: MarketBeat data reported via Ad-hoc-news indicate that investors of record on September 30, 2026, will receive a quarterly dividend of USD 0.92 per share.

That payout corresponds to an annualized dividend of USD 3.68, which translates into a yield of approximately 5.4 percent at prevailing share prices around USD 67.79 as of September 18, 2026, according to the same coverage by Ad-hoc-news.

The combination of a newly established 52-week low and a dividend yield in the mid-single-digit range means that, for income-focused shareholders, the cash distributions can act as a counterbalance to near-term share price volatility, even as the stock trades well below recent moving averages as noted by Ad-hoc-news.

Institutional positioning and FY 2026 expectations

Beyond price action, institutional investors have been adjusting their exposure to National Health Investors in 2026. According to a Form 13F overview cited by MarketBeat on September 20, 2026, Bank of America Corp DE purchased 1,019,379 shares of National Health Investors in the second quarter, a position valued at approximately USD 77,738,000.

The same filing summary from MarketBeat notes that Bank of America Corp DE owned about 2.08 percent of National Health Investors as of its most recent SEC filing covering the second quarter of 2026.

According to forward-looking estimates compiled by MarketBeat, equities research analysts currently anticipate that National Health Investors will post earnings per share of roughly USD 4.76 for the current fiscal year 2026, a figure that sits within the company’s guidance range of USD 4.74 to USD 4.79.

Analyst views and risk considerations

The positioning of National Health Investors stock at the new 52-week low suggests that markets are weighing the stability of its earnings and dividend against sector-specific risks, such as occupancy trends and reimbursement dynamics for healthcare operators, even though the FY 2026 EPS guidance of USD 4.74 to USD 4.79 remains intact according to the outlook overview carried by Ad-hoc-news.

For investors, the key quantified checkpoint now lies in how reported EPS for FY 2026 will match or diverge from the guided range and consensus expectation around USD 4.76, because any shortfall or upside could quickly recalibrate the roughly 14 times valuation multiple implied by the current share price near the 52-week low as illustrated by the comparison in the analysis linked by Ad-hoc-news.

National Health Investors stock at USD 67.79 as of September 18, 2026

As of the last completed trading day on September 18, 2026, National Health Investors stock on the New York Stock Exchange last traded around USD 67.79, with an intraday low of USD 67.56 and a prior close of USD 69.23, placing the shares at the bottom of their 52-week trading band and implying a dividend yield of approximately 5.4 percent based on an annualized payout of USD 3.68.

More news and analyses on National Health Investors stock